• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PRIMA-1MET 使突变型 p53 重新激活,诱导多条信号通路汇聚到细胞凋亡。

Mutant p53 reactivation by PRIMA-1MET induces multiple signaling pathways converging on apoptosis.

机构信息

Department of Oncology-Pathology, Cancer Center Karolinska, Karolinska Institutet, Stockholm, Sweden.

出版信息

Oncogene. 2010 Mar 4;29(9):1329-38. doi: 10.1038/onc.2009.425. Epub 2009 Nov 30.

DOI:10.1038/onc.2009.425
PMID:19946333
Abstract

The low molecular weight compound PRIMA-1(MET) reactivates mutant p53 and triggers mutant p53-dependent apoptosis in human tumor cells. We investigated the effect of PRIMA-1(MET) on global gene expression using microarray analysis of Saos-2 cells expressing His273 mutant p53 and parental p53 null Saos-2 cells. PRIMA-1(MET) affected transcription of a significantly larger number of genes in the mutant p53-expressing cells compared to the p53 null cells. Genes affected by PRIMA-1(MET) in a mutant p53-dependent manner include the cell-cycle regulators GADD45B and 14-3-3gamma and the pro-apoptotic Noxa. Several of the affected genes are known p53 target genes and/or contain p53 DNA-binding motifs. We also found mutant p53-dependent disruption of the cytoskeleton, as well as transcriptional activation of the XBP1 gene and cleavage of its mRNA, a marker for endoplasmic reticulum stress. Our data show that PRIMA-1(MET) induces apoptosis through multiple transcription-dependent and -independent pathways. Such integral engagement of multiple pathways leading to apoptosis is consistent with restoration of wild-type properties to mutant p53 and is likely to reduce the risk of drug resistance development in clinical applications of PRIMA-1(MET).

摘要

低分子量化合物 PRIMA-1(MET)可使突变型 p53 重新激活,并在人肿瘤细胞中引发依赖于突变型 p53 的细胞凋亡。我们使用表达 His273 突变型 p53 的 Saos-2 细胞和具有野生型 p53 的 Saos-2 细胞进行微阵列分析,研究了 PRIMA-1(MET)对整体基因表达的影响。与 p53 缺失的细胞相比,PRIMA-1(MET)在表达突变型 p53 的细胞中影响了更多数量的基因转录。PRIMA-1(MET)以依赖于突变型 p53 的方式影响的基因包括细胞周期调节因子 GADD45B 和 14-3-3γ以及促凋亡基因 Noxa。受 PRIMA-1(MET)影响的几个基因是已知的 p53 靶基因和/或含有 p53 DNA 结合基序。我们还发现突变型 p53 依赖性细胞骨架破坏,以及 XBP1 基因的转录激活和其 mRNA 的切割,这是内质网应激的一个标志。我们的数据表明,PRIMA-1(MET)通过多种转录依赖和非依赖途径诱导细胞凋亡。这种导致细胞凋亡的多种途径的整体参与与恢复突变型 p53 的野生型特性一致,并且可能降低 PRIMA-1(MET)在临床应用中产生耐药性的风险。

相似文献

1
Mutant p53 reactivation by PRIMA-1MET induces multiple signaling pathways converging on apoptosis.PRIMA-1MET 使突变型 p53 重新激活,诱导多条信号通路汇聚到细胞凋亡。
Oncogene. 2010 Mar 4;29(9):1329-38. doi: 10.1038/onc.2009.425. Epub 2009 Nov 30.
2
A transcriptional activation function of p53 is dispensable for and inhibitory of its apoptotic function.p53的转录激活功能对其凋亡功能而言并非必需,反而具有抑制作用。
Oncogene. 2001 Feb 8;20(6):659-68. doi: 10.1038/sj.onc.1204139.
3
Mutant p53 protein expression interferes with p53-independent apoptotic pathways.突变型p53蛋白表达会干扰不依赖p53的凋亡途径。
Oncogene. 1998 Jun 25;16(25):3269-77. doi: 10.1038/sj.onc.1201867.
4
Mutated and non-mutated TP53 as targets in the treatment of leukaemia.突变型和非突变型TP53作为白血病治疗的靶点。
Br J Haematol. 2008 May;141(4):445-53. doi: 10.1111/j.1365-2141.2008.07046.x. Epub 2008 Mar 12.
5
Differential involvement of the CD95 (Fas/APO-1) receptor/ligand system on apoptosis induced by the wild-type p53 gene transfer in human cancer cells.CD95(Fas/APO-1)受体/配体系统在野生型p53基因转导诱导人癌细胞凋亡中的差异作用。
Oncogene. 1999 Apr 1;18(13):2189-99. doi: 10.1038/sj.onc.1202561.
6
Exogenous mutant p53 DNA enhanced cisplatin-induced apoptosis in TSGH-8301 human bladder cancer cells.外源性突变型p53 DNA增强了顺铂诱导的TSGH-8301人膀胱癌细胞凋亡。
Anticancer Res. 2000 Jan-Feb;20(1A):329-36.
7
Oncogenic mutation of the p53 gene derived from head and neck cancer prevents cells from undergoing apoptosis after DNA damage.源自头颈癌的p53基因致癌突变会阻止细胞在DNA损伤后发生凋亡。
Int J Oncol. 2007 May;30(5):1089-97.
8
Gene expression profile in a glioma cell line resistant to cell death induced by the chimeric tumor suppressor-1 (CTS-1), a dominant-positive variant of p53--the role of NFkappaB.胶质细胞瘤细胞系对嵌合肿瘤抑制因子-1(CTS-1)诱导的细胞死亡的抗性中的基因表达谱--NFkappaB 的作用。CTS-1 是 p53 的显性阳性变体。
Carcinogenesis. 2010 Mar;31(3):411-8. doi: 10.1093/carcin/bgp319. Epub 2009 Dec 16.
9
Induction and endoplasmic reticulum location of BIK/NBK in response to apoptotic signaling by E1A and p53.BIK/NBK在E1A和p53凋亡信号作用下的诱导及内质网定位
Oncogene. 2002 Apr 11;21(16):2534-44. doi: 10.1038/sj.onc.1205340.
10
Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems.卵巢癌细胞系中顺铂耐药与p53基因突变及bax表达降低之间的关联。
Cancer Res. 1996 Feb 1;56(3):556-62.

引用本文的文献

1
A novel approach for target deconvolution from phenotype-based screening using knowledge graph.一种使用知识图谱从基于表型的筛选中进行靶点反卷积的新方法。
Sci Rep. 2025 Jan 18;15(1):2414. doi: 10.1038/s41598-025-86166-w.
2
Correlations between Molecular Alterations, Histopathological Characteristics, and Poor Prognosis in Esophageal Adenocarcinoma.食管腺癌分子改变、组织病理学特征与预后不良之间的相关性
Cancers (Basel). 2023 Feb 23;15(5):1408. doi: 10.3390/cancers15051408.
3
Targeting p53 pathways: mechanisms, structures, and advances in therapy.
靶向 p53 通路:机制、结构和治疗进展。
Signal Transduct Target Ther. 2023 Mar 1;8(1):92. doi: 10.1038/s41392-023-01347-1.
4
The anti-cancer agent APR-246 can activate several programmed cell death processes to kill malignant cells.抗癌药物 APR-246 可以激活几种程序性细胞死亡过程来杀死恶性细胞。
Cell Death Differ. 2023 Apr;30(4):1033-1046. doi: 10.1038/s41418-023-01122-3. Epub 2023 Feb 4.
5
Eprenetapopt in the Post-Transplant Setting: Mechanisms and Future Directions.移植后环境中的依普奈妥单抗:作用机制与未来方向
J Clin Oncol. 2022 Dec 1;40(34):3994-3997. doi: 10.1200/JCO.22.01505. Epub 2022 Sep 7.
6
Triptolide promotes degradation of the unfolded gain-of-function Tp53 mutant protein by initiating heat shock protein 70 transcription in non-small cell lung cancer.雷公藤甲素通过启动非小细胞肺癌中热休克蛋白70的转录促进功能获得性p53突变蛋白的降解。
Transl Lung Cancer Res. 2022 May;11(5):802-816. doi: 10.21037/tlcr-22-312.
7
Redox Sensitive Cysteine Residues as Crucial Regulators of Wild-Type and Mutant p53 Isoforms.氧化还原敏感半胱氨酸残基作为野生型和突变型 p53 异构体的关键调节剂。
Cells. 2021 Nov 12;10(11):3149. doi: 10.3390/cells10113149.
8
APR-246 induces apoptosis and enhances chemo-sensitivity via activation of ROS and TAp73-Noxa signal in oesophageal squamous cell cancer with TP53 missense mutation.APR-246通过激活ROS和TAp73-Noxa信号诱导食管鳞状细胞癌(具有TP53错义突变)凋亡并增强化疗敏感性。
Br J Cancer. 2021 Nov;125(11):1523-1532. doi: 10.1038/s41416-021-01561-0. Epub 2021 Oct 1.
9
Ascorbate Inhibits Proliferation and Promotes Myeloid Differentiation in -Mutant Leukemia.抗坏血酸盐抑制突变型白血病中的细胞增殖并促进髓系分化。
Front Oncol. 2021 Aug 23;11:709543. doi: 10.3389/fonc.2021.709543. eCollection 2021.
10
Therapeutic Strategies Targeting Tumor Suppressor Genes in Pancreatic Cancer.胰腺癌中针对肿瘤抑制基因的治疗策略
Cancers (Basel). 2021 Aug 3;13(15):3920. doi: 10.3390/cancers13153920.